Abstract
The aim of this paper was to critically review the current treatment of anxiety disorders including general anxiety disorder, panic disorder, social anxiety disorder and post-traumatic stress disorder. For all these disorders, this paper will suggest treatment guidelines based on literature data as well as personal experience. Obsessive compulsive disorder (OCD) even considered in DSM IV as an anxiety disorder is somewhere different from the other anxiety disorder (almost lack of placebo response, efficacy of cognitive- behavioural therapy and deep brain stimulation).
Keywords: Benzodiazepines, serotonin selective reuptake inhibitors (SSRIs), antidepressants, generalized anxiety disorder (GAD), panic disorder (PD), social anxiety disorder (SAD), post traumatic stress disorder (PTSD).
Current Psychopharmacology
Title:A Critical Approach of the Current Treatment of Anxiety Disorders
Volume: 2
Author(s): Michel Bourin and Florence Thibaut
Affiliation:
Keywords: Benzodiazepines, serotonin selective reuptake inhibitors (SSRIs), antidepressants, generalized anxiety disorder (GAD), panic disorder (PD), social anxiety disorder (SAD), post traumatic stress disorder (PTSD).
Abstract: The aim of this paper was to critically review the current treatment of anxiety disorders including general anxiety disorder, panic disorder, social anxiety disorder and post-traumatic stress disorder. For all these disorders, this paper will suggest treatment guidelines based on literature data as well as personal experience. Obsessive compulsive disorder (OCD) even considered in DSM IV as an anxiety disorder is somewhere different from the other anxiety disorder (almost lack of placebo response, efficacy of cognitive- behavioural therapy and deep brain stimulation).
Export Options
About this article
Cite this article as:
Bourin Michel and Thibaut Florence, A Critical Approach of the Current Treatment of Anxiety Disorders, Current Psychopharmacology 2013; 2 (2) . https://dx.doi.org/10.2174/2211556011302020002
DOI https://dx.doi.org/10.2174/2211556011302020002 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
DNA Methylation, An Epigenetic Mode of Gene Expression Regulation in Reproductive Science
Current Pharmaceutical Design Functional, Genetic and Biochemical Biomarkers of Peripheral Arterial Disease
Current Medicinal Chemistry Effect of L-Arginine and Selenium on Metabolic Features, Insulin Resistance and Hepatic Function Tests in Obese Women
Current Nutrition & Food Science Evaluation of Current Pharmacological Treatment Options in the Management of Rett Syndrome: From the Present to Future Therapeutic Alternatives.
Current Clinical Pharmacology Histone Cleavage as a Mechanism for Epigenetic Regulation: Current Insights and Perspectives
Current Molecular Medicine Dual Inhibitors of Monoamine Oxidase and Cholinesterase for the Treatment of Alzheimer Disease
Current Topics in Medicinal Chemistry Transmission of HIV-1 in the Face of Neutralizing Antibodies
Current HIV Research The Use of Lectins as Tools to Combat SARS-CoV-2
Current Pharmaceutical Design A Role for Milk Proteins and their Peptides in Cancer Prevention
Current Pharmaceutical Design Molecular Determinants of the Cardiometabolic Phenotype
Endocrine, Metabolic & Immune Disorders - Drug Targets Perspectives and Prospects on mRNA Vaccine Development for COVID-19
Current Medicinal Chemistry Circulating Biomarkers for the Diagnosis and Prognosis of Heart Failure
Current Medicinal Chemistry Recent Development and Future Perspective of Antitubercular Therapy
Anti-Infective Agents in Medicinal Chemistry Metabolic Control of Glia-Mediated Neuroinflammation
Current Alzheimer Research Alpha-7 Nicotinic Receptors in Nervous System Disorders: From Function to Therapeutic Perspectives
Central Nervous System Agents in Medicinal Chemistry Current Management of Neonatal Soft-tissue Sarcomas and Benign Tumors with Local Aggressiveness
Current Pediatric Reviews Role of Chymase in Preeclampsia
Current Vascular Pharmacology P2Y Receptors in the Mammalian Nervous System: Pharmacology, Ligands and Therapeutic Potential
CNS & Neurological Disorders - Drug Targets Risk Factors for Lung Cancer in Never Smokers: A Recent Review Including Genetics
Current Respiratory Medicine Reviews Multi-Target Directed Compounds with Antioxidant and/or Anti- Inflammatory Properties as Potent Agents for Alzheimer’s Disease
Medicinal Chemistry